Clinical Trial: Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Liver Transplant
Study Type: INTERVENTIONAL
Official Title: Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates (CTOT-44)
Brief Summary:
This is a multi-center clinical trial in Cytomegalovirus (CMV) seronegative prospective liver transplant recipients to determine the efficacy of two doses of Cytomegalovirus-Modified Vaccinia Ankara (CMV-MVA) Triplex CMV vaccine pre-transplant.The primary objective is to assess the effect of pre-transplant (Tx) Triplex vaccination on duration of CMV antiviral therapy (AVT) within the first 100 days post-Tx in CMV seronegative (R-) and seropositive donor (D+) (D+R-) liver transplant recipients (LTxRs).A…
Read more